(Q36646218)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087676%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

The metabolic syndrome and schizophrenia: the latest evidence and nursing guidelines for management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087676%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087676%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Kim Foster

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087676%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

T Park

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087676%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087676%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychiatric and Mental Health Nursing

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087676%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087676%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087676%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

730-734

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17087676%20AND%20SRC:MED&resulttype=core&format=json

Metabolic effects associated with atypical antipsychotic medications

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2850.2006.01026.X

The metabolic syndrome during atypical antipsychotic drug treatment: mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2850.2006.01026.X

Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2850.2006.01026.X

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2850.2006.01026.X

Schizophrenia, the metabolic syndrome and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2850.2006.01026.X

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2850.2006.01026.X

Atypical antipsychotics and weight gain--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2850.2006.01026.X

Understanding the new and evolving profile of adverse drug effects in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2850.2006.01026.X